NCT03209349

Brief Summary

This study evaluates how often patients without sedation that receive screening sigmoidoscopy are able to have their full colon examined without significant discomfort by comparing a new colonoscopy technique known as the water exchange technique to the traditional air insufflation technique. It compares the differences between complete colon exam rates for water exchange when compared to the traditional air technique. Patients will be randomised and blinded to the procedure type. Previous studies have shown that the water exchange method is associated with a significant reduction in discomfort and often allows patients to receive colonoscopy without sedation or with only minimal sedation. However, the potential for water exchange to be used in the screening setting has yet to be evaluated. As per standard practices in sigmoidoscopy screening, patients will not be sedated. However, unlike standard practices in sigmoidoscopy screening, while maintaining minimal levels of discomfort, the investigators will attempt to scope beyond the distal colon.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P25-P50 for not_applicable colorectal-cancer

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable colorectal-cancer

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

June 14, 2017

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 6, 2017

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2022

Completed
Last Updated

November 7, 2022

Status Verified

November 1, 2022

Enrollment Period

5.4 years

First QC Date

June 14, 2017

Last Update Submit

November 3, 2022

Conditions

Keywords

Sigmoidoscopy

Outcome Measures

Primary Outcomes (1)

  • Full colon exam

    Ability for patient to receive full exam of the colon with minimal discomfort

    Immediately following the procedure

Secondary Outcomes (2)

  • Recalled Discomfort

    Immediately following the procedure

  • Adenoma detection rates

    Immediately following the procedure

Study Arms (2)

Water Exchange Sigmoidoscopy

EXPERIMENTAL

As per standard practices, the patient will be walked to the procedure room and positioned in the left lateral position on the procedure bed, without pre-operative anesthesia. The procedures will be completed within the ambulatory endoscopy clinic at Kelowna General Hospital. The study will use the same colonoscopes that are already being used at KGH for colonoscopy. These are the Olympus 190 series colonoscopes. They can and will be fitted to support both water and air exchange. For patients assigned the water exchange intervention arm, the insertion of the scope will be followed by infusion and suction of water to minimally distend the lumen. If the lumen does not open, the instrument will be retracted slightly and the infusion started again. As the scope is inserted and progressed through the intestinal lumen some of the infused water will be suctioned back constantly, exchanging clean for opaque water.

Procedure: Water Exchange Sigmoidoscopy

Air Insufflation Sigmoidoscopy

ACTIVE COMPARATOR

As per standard practices, the patient will be walked to the procedure room and positioned in the left lateral position on the procedure bed, without pre-operative anesthesia. The procedures will be completed within the ambulatory endoscopy clinic at Kelowna General Hospital. The study will use the same colonoscopes that are already being used at KGH for colonoscopy. These are the Olympus 190 series colonoscopes. They can and will be fitted to support both water and air exchange. For patients assigned to the air insufflation intervention arm, extended sigmoidoscopy will be performed with the minimum insufflation required to reach the cecum.

Procedure: Air Insufflation Sigmoidoscopy

Interventions

See arm description.

Water Exchange Sigmoidoscopy

See arm description.

Air Insufflation Sigmoidoscopy

Eligibility Criteria

Age50 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Asymptomatic average risk (as per BC colon screening guidelines) individuals
  • Ages 50-74 years of age

You may not qualify if:

  • A sigmoidoscopy or colonoscopy within 10 years,
  • A FIT within 2 years,
  • Individuals classified with any high-risk screening criteria in accordance to the
  • BC colon screening guidelines including:
  • a personal history of adenoma,
  • a first degree relative that was diagnosed with colorectal cancer or multiple adenomas under the age of 60,
  • two or more first degree relatives with colorectal cancer at any age, longstanding inflammatory bowel diseases,
  • a family history of familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer, - Individuals presenting with rectal pain, rectal bleeding, abdominal pain, or unintentional weight loss at the time of the examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sepulveda Ambulatory Care Center

North Hills, California, 91343, United States

Location

Brent Parker

Kelowna, British Columbia, V1Y 9Z5, Canada

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Rafael Perini, MD

    Kelowna General Hospital, Department of Gastroenterology

    PRINCIPAL INVESTIGATOR
  • Adrian Bak, MD

    Kelowna General Hospital, Department of Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
The study interviewer and the patient will be blinded to the procedure type both during and following the procedure type both during and following the procedure by concealing the monitors and relevant equipment from their sight. The physician performing the procedure will be blinded to the procedure type until the patient is brought into the procedure room. They will open the allocation envelope once the patient has been placed and positioned on the procedure bed. Neither the patient, the RN, nor the research assistant, who will be conducting the follow-up interviews, will be informed of the study arm. Patient assignment will be managed by the study project manager and will be kept in a password protected file and will remain separate from other study data until the time of the final analysis.
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2017

First Posted

July 6, 2017

Study Start

June 14, 2017

Primary Completion

November 3, 2022

Study Completion

November 3, 2022

Last Updated

November 7, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations